Neumind
PrivateLast Round
Grant
Jan 1, 2023
Total Funding Raised
$198,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Neumind operates in Healthcare & Life Sciences and is based in the United Kingdom. Its latest recorded funding round was a Grant round in January 2023.
Neumind is a health technology company that provides a digital neurorehabilitation platform designed to support patients, caregivers, and clinicians with cognitive recovery tools.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neumind Comparables
Compare Neumind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Constant Therapy Health | 82% | |
| Brain in Hand | 67% | |
| MindMaze | 64% |
For institutional investors. Book with your work email.
Neumind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2023 | ||||
| Grant | May 31, 2022 | ||||
| Accelerator | Sep 10, 2021 | ||||
| Grant | Jan 12, 2021 | ||||
| Accelerator | Oct 26, 2020 | ||||
Accelerator | Sep 19, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neumind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Accelerator |
| Bethnal Green Ventures | Accelerator |
| EPSRC | Grant |
| The King's Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 61% MoM.
- Aug 22, 2026
Monthly visitors grew 93% MoM.
For institutional investors. Book with your work email.
Neumind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neumind's valuation, stock price, and market status.
Is Neumind a public or private company?
Neumind is a private company.
What is the current stock price of Neumind?
Neumind is a private company, so its shares have no public market price. Caplight tracks Neumind's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neumind worth (valuation)?
Valuation information for Neumind is not publicly available.
Can I buy Neumind stock?
Neumind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neumind's last funding round?
Neumind's most recent funding round was Grant on January 1, 2023.
Who are the main investors in Neumind?
Key investors in Neumind include Bethnal Green Ventures.
Will Neumind IPO soon?
No public IPO plans have been announced for Neumind.
How can I track Neumind secondary market activity?
Caplight tracks bids, offers, and trades in Neumind's shares on secondary markets.